Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study
Clinical Nutrition · 2023-08 · 42 (8) · 1389-1398
DOI: 10.1016/j.clnu.2023.06.027 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2023-08. Verfasst von Ignacio Ruiz-García und 20 weiteren Autor:innen. Beteiligte Einrichtung: UGC Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicin…. Hauptthemen laut MEDLINE: Antioxidants, Prediabetic State. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Junta de Andalucia Consejería de Salud y Familias.
Abstract (Originalsprache)
BACKGROUND: Oleocanthal and oleacein are olive oil phenolic compounds with well known anti-inflammatory and anti-oxidant properties. The main evidence, however, is provided by experimental studies. Few human studies have examined the health benefits of olive oils rich in these biophenols. Our aim was to assess the health properties of rich oleocanthal and oleacein extra virgin olive oil (EVOO), compared to those of common olive oil (OO), in people with prediabetes and obesity. METHODS: Randomised, double-blind, crossover trial done in people aged 40-65 years with obesity (BMI 30-40 kg/m2) and prediabetes (HbA1c 5.7-6.4%). The intervention consisted in substituting for 1 month the oil used for food, both raw and cooked, by EVOO or OO. No changes in diet or physical activity were recommended. The primary outcome was the inflammatory status. Secondary outcomes were the oxidative status, body weight, glucose handling and lipid profile. An ANCOVA model adjusted for age, sex and treatment administration sequence was used for the statistical analysis. RESULTS: A total of 91 patients were enrolled (33 men and 58 women) and finished the trial. A decrease in interferon-γ was observed after EVOO treatment, reaching inter-treatment differences (P = 0.041). Total antioxidant status increased and lipid and organic peroxides decreased after EVOO treatment, the changes reaching significance compared to OO treatment (P < 0.05). Decreases in weight, BMI and blood glucose (p < 0.05) were found after treatment with EVOO and not with OO. CONCLUSIONS: Treatment with EVOO rich in oleocanthal and oleacein differentially improved oxidative and inflammatory status in people with obesity and prediabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UGC Endocrinología y Nutrición, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, CIBER de Diabetes y Enfermedades Metabólic…
- Departamento de Fitoquímica de los Alimentos, Instituto de la Grasa - CSIC, Sevilla, Spain.
- Departamento de Fisiología Humana, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
- Departamento de Farmacología, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
- Centro de Salud El Palo, Consejería de Salud y Familias, Junta de Andalucía, Málaga, Spain.
- Hospital Quironsalud, Marbella, Spain.
Förderung
- Instituto de Salud Carlos III
- Junta de Andalucia Consejería de Salud y Familias
Zitieren
APA
Ruiz-García, I., Ortíz-Flores, R., Badía, R., García-Borrego, A., García-Fernández, M., Lara, E., Martín-Montañez, E., García-Serrano, S., Valdés, S., Gonzalo, M., Tapia-Guerrero, M. J., Fernández-García, J. C., Sánchez-García, A., Muñoz-Cobos, F., Calderón-Cid, M., El-Bekay, R., Covas, M. I., Rojo-Martínez, G., Olveira, G., …, & Bermúdez-Silva, F. J. (2023). Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study. Clinical Nutrition, 42(8), 1389-1398. https://doi.org/10.1016/j.clnu.2023.06.027
Vancouver
Ruiz-García I, Ortíz-Flores R, Badía R, García-Borrego A, García-Fernández M, Lara E, et al. Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study. Clinical Nutrition. 2023;42(8):1389-1398. doi:10.1016/j.clnu.2023.06.027
BibTeX
@article{RuizGarca2023,
author = {Ruiz-García, Ignacio and Ortíz-Flores, Rodolfo and Badía, Rocío and García-Borrego, Aranzazu and García-Fernández, María and Lara, Estrella and Martín-Montañez, Elisa and García-Serrano, Sara and Valdés, Sergio and Gonzalo, Montserrat and Tapia-Guerrero, María-José and Fernández-García, José-Carlos and Sánchez-García, Alicia and Muñoz-Cobos, Francisca and Calderón-Cid, Miguel and El-Bekay, Rajaa and Covas, María-Isabel and Rojo-Martínez, Gemma and Olveira, Gabriel and Romero-Zerbo, Silvana-Yanina and Bermúdez-Silva, Francisco-Javier},
title = {Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study},
journal = {Clinical Nutrition},
year = {2023},
volume = {42},
number = {8},
pages = {1389--1398},
doi = {10.1016/j.clnu.2023.06.027}
}
EUVIMED